Alpha Tau Medical (DRTS) Other Non Operating Income (2023 - 2024)
Alpha Tau Medical (DRTS) posted Other Non Operating Income of $8.1 million for Q4 2024, up 230.2% sequentially from -$6.3 million in Q3 2024, and down 24.74% YoY from $10.8 million in Q1 2024.
Alpha Tau Medical (DRTS) Other Non Operating Income (2023 - 2024) Analysis & Trends
Alpha Tau Medical has reported Other Non Operating Income for 2 years, with the latest figure at $8.1 million in Q4 2024.
- Quarterly Other Non Operating Income fell 24.74% year-over-year to $8.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $6.6 million (changed N/A YoY) and the FY2025 annual result came in at $3.8 million, down 17.34% from the prior year.
- Other Non Operating Income advanced to $8.1 million in Q4 2024 per DRTS's latest filing, from -$6.3 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $10.8 million in Q4 2023 and troughed at -$6.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 8.14 Mn |
| Sep 30, 2024 | -6.25 Mn |
| Dec 31, 2023 | 10.82 Mn |
| Sep 30, 2023 | -6.11 Mn |